Hep C - euro adhoc: Intercell AG / other / Intercell's Hepatitis C vaccine meets success criteria for further development -

euro adhoc: Intercell AG / other / Intercell's Hepatitis C vaccine meets success criteria for further development -
Presseportal - Jan 31 9:08 AM
31.01.2006 Intercell (VSE; "ICLL") today announced initial data from a clinical trial aiming at the optimization of its therapeutic Hepatitis C vaccine IC41. Results ...Save to My Web

YOU ARE HERE:
Aidsmap - Jan 23 4:58 PM
Fatigue is more than twice as prevalent as depression during anti-hepatitis C (HCV) treatment in HIV-positive individuals, according to a study presented to the Second International Workshop on HIV and Hepatitis Coinfection, held in Amsterdam earlier this month.Save to My Web

Health Business
UPI - Jan 23 1:33 PM
VANCOUVER, British Columbia, Jan. 23 (UPI) -- Migenix said Monday it would launch early in the second quarter of 2006 a trial of hepatitis C drug MX-3253.Save to My Web

YOU ARE HERE:
Aidsmap - Feb 17 4:58 AM
Virological response to hepatitis C therapy after four weeks appears to predict who will have a successful response to a full course of treatment in HIV-positive people coinfected with hepatitis C genotypes 1 or 3, according to findings from two studies presented last week at the Thirteenth Conference on Retroviruses and Opportunistic Infections in Denver.Save to My Web

Peregrine advances hepatitis C drug
Pharmaceutical Business Review - Feb 16 6:24 PM
Peregrine Pharmaceuticals, a biopharmaceutical company focusing on viral diseases and cancer, has completed planned patient enrollment and dosing in its initial phase I clinical trial for Tarvacin anti-viral in the treatment of chronic hepatitis C virus infection.Save to My Web